Pesquisa | BVS Violência e Saúde

1.

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting.

Mittelman, Moshe; Magen, Ori; Barda, Noam; Dagan, Noa; Oster, Howard S; Leader, Avi; Balicer, Ran.

Blood ; 139(10): 1439-1451, 2022 03 10.

Artigo em Inglês | MEDLINE | ID: mdl-34662390

2.

[TRANSLATIONAL MEDICINE IN MALIGNANT HEMATOLOGY].

Mittelman, Moshe.

Harefuah ; 163(2): 125-132, 2024 Feb.

Artigo em Hebraico | MEDLINE | ID: mdl-38431863

3.

Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.

Madry, Krzysztof; Lis, Karol; Fenaux, Pierre; Bowen, David; Symeonidis, Argiris; Mittelman, Moshe; Stauder, Reinhard; Cermák, Jaroslav; Sanz, Guillermo; Hellström-Lindberg, Eva; Langemeijer, Saskia; Malcovati, Luca; Germing, Ulrich; Holm, Mette Skov; Guerci-Bresler, Agnes; Culligan, Dominic; Sanhes, Laurence; Kotsianidis, Ioannis; van Marrewijk, Corine; Crouch, Simon; de Witte, Theo; Smith, Alex.

Br J Haematol ; 200(4): 451-461, 2023 02.

Artigo em Inglês | MEDLINE | ID: mdl-36335984

4.

Long-Term Safety and Efficacy of Eltrombopag for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia: Results of the ASPIRE Extension Study.

Mittelman, Moshe; Platzbecker, Uwe; Grosicki, Sebastian; Lawniczek, Tomasz; Zhu, Zewen; Selleslag, Dominik.

Acta Haematol ; 146(5): 373-378, 2023.

Artigo em Inglês | MEDLINE | ID: mdl-37231838

5.

The Effect of The Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes A Study by the Israeli MDS Working Group.

Merkel, Drorit; Soffer, Shelly; Filanovsky, Kalman; Braester, Andrei; Fibach, Eitan; Dana, Mutaz; Ofran, Yishai; Greenbaum, Uri; Nagler, Arnon; Amitai, Irina; Mittelman, Moshe.

Acta Haematol ; 2023 Dec 16.

Artigo em Inglês | MEDLINE | ID: mdl-38104534

6.

Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.

Henry, David H; Glaspy, John; Harrup, Rosemary; Mittelman, Moshe; Zhou, Amy; Carraway, Hetty E; Bradley, Charles; Saha, Gopal; Modelska, Katharina; Bartels, Pamela; Leong, Robert; Yu, Kin-Hung P.

Am J Hematol ; 97(2): 174-184, 2022 02 01.

Artigo em Inglês | MEDLINE | ID: mdl-34724251

7.

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.

Avivi, Irit; Balaban, Roi; Shragai, Tamir; Sheffer, Gabi; Morales, Miguel; Aharon, Anat; Lowenton-Spier, Noa; Trestman, Svetlana; Perry, Chava; Benyamini, Noam; Mittelman, Moshe; Tabib, Yaara; Bar Lev, Tali; Zavaro, Mor; Herishanu, Yair; Luttwak, Efrat; Cohen, Yael C.

Br J Haematol ; 195(2): 186-193, 2021 10.

Artigo em Inglês | MEDLINE | ID: mdl-34196388

8.

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic Patients.

Oster, Howard S; Gvili Perelman, Moran; Kolomansky, Albert; Neumann, Drorit; Mittelman, Moshe.

Acta Haematol ; 144(3): 252-258, 2021.

Artigo em Inglês | MEDLINE | ID: mdl-32662775

9.

Gaucher disease, myelodysplastic syndrome and ICUS.

Ruchlemer, Rosa; Mittelman, Moshe; Zimran, Ari.

Blood Cells Mol Dis ; 80: 102373, 2020 02.

Artigo em Inglês | MEDLINE | ID: mdl-31718920

10.

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia.

Dickinson, Michael; Cherif, Honar; Fenaux, Pierre; Mittelman, Moshe; Verma, Amit; Portella, Maria Socorro O; Burgess, Paul; Ramos, Pedro Marques; Choi, Jeea; Platzbecker, Uwe.

Blood ; 132(25): 2629-2638, 2018 12 20.

Artigo em Inglês | MEDLINE | ID: mdl-30305280

11.

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.

Hoeks, Marlijn; Yu, Ge; Langemeijer, Saskia; Crouch, Simon; de Swart, Louise; Fenaux, Pierre; Symeonidis, Argiris; Cermák, Jaroslav; Hellström-Lindberg, Eva; Sanz, Guillermo; Stauder, Reinhard; Holm, Mette Skov; Mittelman, Moshe; Madry, Krzysztof; Malcovati, Luca; Tatic, Aurelia; Almeida, Antonio Medina; Germing, Ulrich; Savic, Aleksandar; Simec, Njetocka Gredelj; Culligan, Dominic; Itzykson, Raphael; Guerci-Bresler, Agnes; Slama, Borhane; Droste, Jackie; van Marrewijk, Corine; van de Loosdrecht, Arjan; Blijlevens, Nicole; van Kraaij, Marian; Bowen, David; de Witte, Theo; Smith, Alex.

Haematologica ; 105(3): 640-651, 2020 03.

Artigo em Inglês | MEDLINE | ID: mdl-31278207

12.

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.

de Swart, Louise; Crouch, Simon; Hoeks, Marlijn; Smith, Alex; Langemeijer, Saskia; Fenaux, Pierre; Symeonidis, Argiris; Cermâk, Jaroslav; Hellström-Lindberg, Eva; Stauder, Reinhard; Sanz, Guillermo; Mittelman, Moshe; Holm, Mette Skov; Malcovati, Luca; Madry, Krzysztof; Germing, Ulrich; Tatic, Aurelia; Savic, Aleksandar; Almeida, Antonio Medina; Gredelj-Simec, Njetocka; Guerci-Bresler, Agnes; Beyne-Rauzy, Odile; Culligan, Dominic; Kotsianidis, Ioannis; Itzykson, Raphael; van Marrewijk, Corine; Blijlevens, Nicole; Bowen, David; de Witte, Theo.

Haematologica ; 105(3): 632-639, 2020 03.

Artigo em Inglês | MEDLINE | ID: mdl-31171638

13.

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma.

Markus, Efrat; Trestman, Svetlana; Cohen, Yael; Angel, Yoel; Sofer, Yael; Mittelman, Moshe; Avivi, Irit; Stern, Naftali; Izkhakov, Elena.

BMC Cancer ; 20(1): 489, 2020 May 30.

Artigo em Inglês | MEDLINE | ID: mdl-32473631

14.

Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survival.

Joffe, Erel; Greenbaum, Uri; Man-El, Gili; Filanovsky, Kalman; Oster, Howard S; Levi, Itai; Raanani, Pia; Avivi, Irit; Mittelman, Moshe.

Hematol Oncol ; 38(5): 782-791, 2020 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-32632931

15.

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible.

Kolomansky, Albert; Hiram-Bab, Sahar; Ben-Califa, Nathalie; Liron, Tamar; Deshet-Unger, Naamit; Mittelman, Moshe; Oster, Howard S; Rauner, Martina; Wielockx, Ben; Neumann, Drorit; Gabet, Yankel.

Int J Mol Sci ; 21(11)2020 May 27.

Artigo em Inglês | MEDLINE | ID: mdl-32471308

16.

The French-American-British classification of myelodysplastic syndromes.

Mittelman, Moshe.

Haematologica ; 108(10): 2559-2560, 2023 10 01.

Artigo em Inglês | MEDLINE | ID: mdl-37779494

17.

Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?

Greenbaum, Uri; Joffe, Erel; Filanovsky, Kalman; Oster, Howard S; Kirgner, Ilya; Levi, Itai; Raanani, Pia; Avivi, Irit; Manor, Esther; Man-El, Gili; Mittelman, Moshe.

Eur J Haematol ; 101(4): 502-507, 2018 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-29956845

18.

Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts.

Oster, Howard S; Svorai-Litvak, Shani; Kirgner, Ilya; Kolomansky, Albert; Siegel, Robert S; Mittelman, Moshe.

Isr Med Assoc J ; 20(10): 608-612, 2018 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-30324776

19.

Is COVID vaccine effective in patients with myeloid malignancy?

Mittelman, Moshe.

Br J Haematol ; 197(6): 656-658, 2022 06.

Artigo em Inglês | MEDLINE | ID: mdl-35277857

20.

Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?

Mittelman, Moshe; Oster, Howard S.

Br J Haematol ; 194(2): 231-233, 2021 07.

Artigo em Inglês | MEDLINE | ID: mdl-34151421

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting.

[TRANSLATIONAL MEDICINE IN MALIGNANT HEMATOLOGY].

Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.

Long-Term Safety and Efficacy of Eltrombopag for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia: Results of the ASPIRE Extension Study.

The Effect of The Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes A Study by the Israeli MDS Working Group.

Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic Patients.

Gaucher disease, myelodysplastic syndrome and ICUS.

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia.

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma.

Kinetics of pre-myelodysplastic syndromes blood values correlate with disease risk and survival.

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible.

The French-American-British classification of myelodysplastic syndromes.

Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?

Myelodysplastic Syndromes Over Time: A Comparison of Two Patient Cohorts.

Is COVID vaccine effective in patients with myeloid malignancy?

Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?